|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004927,
umls-concept:C0013216,
umls-concept:C0034656,
umls-concept:C0040808,
umls-concept:C0043227,
umls-concept:C0205195,
umls-concept:C0205390,
umls-concept:C0239307,
umls-concept:C0332174,
umls-concept:C0684249,
umls-concept:C1442989,
umls-concept:C1518904,
umls-concept:C1563350,
umls-concept:C1563351,
umls-concept:C2603343
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1993-11-5
|
|
pubmed:abstractText |
A randomized trial was conducted in patients with small-cell lung cancer (SCLC) to determine if survival can be improved by a weekly chemotherapy regimen combining various drugs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1858-65
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8410110-Adult,
pubmed-meshheading:8410110-Aged,
pubmed-meshheading:8410110-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8410110-Carcinoma, Small Cell,
pubmed-meshheading:8410110-Drug Administration Schedule,
pubmed-meshheading:8410110-Factor Analysis, Statistical,
pubmed-meshheading:8410110-Female,
pubmed-meshheading:8410110-Humans,
pubmed-meshheading:8410110-Infusions, Intravenous,
pubmed-meshheading:8410110-Lung Neoplasms,
pubmed-meshheading:8410110-Male,
pubmed-meshheading:8410110-Middle Aged,
pubmed-meshheading:8410110-Prognosis,
pubmed-meshheading:8410110-Survival Analysis,
pubmed-meshheading:8410110-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
|
|
pubmed:affiliation |
Department of Medicine, Institut Jules Bordet, Bruxelles, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
